[15-12G] Regulus Therapeutics Inc. SEC Filing

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 15

 

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 001-35670

 

 

 

Regulus Therapeutics Inc.

(Exact name of registrant as specified in its charter)

 

 

 

4224 Campus Point Court, Suite 210

San Diego, CA 92121

(858) 202-6300
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, par value $0.001 per share
(Title of each class of securities covered by this Form)

 

None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)	x
Rule 12g-4(a)(2)	¨
Rule 12h-3(b)(1)(i)	x
Rule 12h-3(b)(1)(ii)	¨
Rule 15d-6	¨
Rule 15d-22(b)	¨

 

Approximate number of holders of record as of the certification or notice date: One (1)

 

 

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Regulus Therapeutics Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

 	REGULUS THERAPEUTICS INC.
 	 
Date: July 7, 2025	By:	/s/ Jaime Huertas
 	 	Name:	Jaime Huertas
 	 	Title:	Secretary